• Latest Posts
In Depth 10 Mar 2021

Can Gene Therapy Cure Blindness?

Biogen Acquires UK Biotech Developing Gene Therapy for Blindness

Gene Therapy Improves Eyesight of Patients With Inherited Blindness

Oxford Spin-out Moves Gene Therapy For Blindness Into Phase III Trial

Oxford Spinout goes for $75M IPO on Nasdaq to Fund Gene Therapy Programs


€40M in Series C for a British Biotech Treating Blindness with Gene Therapy

Oxford’s Nightstar Gene Therapy for Blindness in Men Shines with $35M Fundraiser